Tazobactam/ceftolozane and tobramycin combination therapy in extensively drug-resistant Pseudomonas aeruginosa infections in severe burn injury: a case report

Tazobactam/ceftolozane and tobramycin combination therapy in extensively drug-resistant Pseudomonas aeruginosa infections in severe burn injury: a case report

Abstract Background Combination therapy with tazobactam/ceftolozane (TAZ/CTLZ) and high-dose aminoglycosides has been reported to be efficacious in extensively drug-resistant (XDR)-Pseudomonas aeruginosa infection. However, there are no reports of efficacy in XDR-P. aeruginosa infection for combinat...

Full description

Bibliographic Details
Main Authors: Yuta Ibe, Ryuichiro Kakizaki, Hirotoshi Inamura, Tomoyuki Ishigo, Yoshihiro Fujiya, Hiroyuki Inoue, Shuji Uemura, Satoshi Fujii, Satoshi Takahashi, Eichi Narimatsu, Masahide Fukudo
Format: Article
Language:English
Published: BMC 2023-08-01
Series:Journal of Pharmaceutical Health Care and Sciences
Subjects:
Burns injury
Pseudomonas aeruginosa
Tazobactam/ceftolozane
Tobramycin
Online Access:https://doi.org/10.1186/s40780-023-00294-x

Internet

https://doi.org/10.1186/s40780-023-00294-x

Similar Items